Oxygent


Also found in: Wikipedia.

Oxygent

A perflubron-based synthetic blood substitute which, while it was more effective than Fluosol in transporting O2, nonetheless failed in clinical trials and is not FDA-approved for use in humans.
References in periodicals archive ?
Alliance is developing Oxygent, an intravascular oxygen carrier in Phase 3 development, in the United States, Canada, and Europe in conjunction with Baxter Healthcare Corp.
Double-Crane will conduct clinical trials in the PRC, in accordance with international guidelines, to receive marketing approval for Oxygent in the PRC.
Alliance is developing Oxygent as an intravascular oxygen therapeutic, based on its proprietary PFC and surfactant technologies.
Oxygent is being developed by Alliance in the United States, Canada, and Europe in conjunction with Baxter.
After halting development of its hemoglobin-based substitutes, Baxter Corporation joined with Alliance Pharmaceutical Corporation to create a new company, PFC Therapeutics, which will market Alliance's Oxygent product.
We unfortunately have to take a little time out here in our clinical development before we forge ahead, but this is a huge market that's not going away," says Peter Keipert, director of Oxygent development at Alliance.
Oxygent is being developed in the United States, Canada, and Europe in conjunction with Baxter Healthcare Corporation.
Oxygent can be used during surgical operations and clinical trials are currently underway for this substitute.
CHAPTER SIX: SYNTHETIC BLOOD PRODUCTS MARKET Driving Forces of the Synthetic Blood Products Industry Variables Influencing the Supply and Demand of Donated Blood Recombinant Factor Market Market Size Market Participants Oxygen Carrier Market Market Size Synthetic Blood Products in Clinical Development Hemopure (OPK BioTech) Oxygent (Sanguine Corp.
Ltd ("IL YANG") announced the signing of a Licensing, Development and Marketing Agreement ("Agreement") between PFC Therapeutics and IL YANG, granting IL YANG exclusive rights to distribute and commercialize Oxygent in South Korea.
Oxygent is a milky white concoction now being used in clinical trials, and it appears to be headed for federal approval and widespread use (1).